• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In Reply to 'Artificial Intelligence Can Predict GFR Decline During the Course of ADPKD' and 'Linear and Nonlinear Estimated GFR Slopes in ADPKD Patients Reaching ESRD'.

作者信息

Brosnahan Godela M, Moore Charity G, Abebe Kaleab Z

机构信息

University of Colorado Denver, Aurora, CO.

University of Pittsburgh, Pittsburgh, PA.

出版信息

Am J Kidney Dis. 2018 Jun;71(6):913. doi: 10.1053/j.ajkd.2018.02.349. Epub 2018 Mar 30.

DOI:10.1053/j.ajkd.2018.02.349
PMID:29609976
Abstract
摘要

相似文献

1
In Reply to 'Artificial Intelligence Can Predict GFR Decline During the Course of ADPKD' and 'Linear and Nonlinear Estimated GFR Slopes in ADPKD Patients Reaching ESRD'.回复《人工智能可预测常染色体显性多囊肾病病程中的肾小球滤过率下降》及《终末期肾病常染色体显性多囊肾病患者的线性和非线性估计肾小球滤过率斜率》
Am J Kidney Dis. 2018 Jun;71(6):913. doi: 10.1053/j.ajkd.2018.02.349. Epub 2018 Mar 30.
2
Linear and Nonlinear Estimated GFR Slopes in ADPKD Patients Reaching ESRD.达到终末期肾病的常染色体显性多囊肾病患者的线性和非线性估计肾小球滤过率斜率
Am J Kidney Dis. 2018 Jun;71(6):912-913. doi: 10.1053/j.ajkd.2018.01.052. Epub 2018 Mar 30.
3
Artificial Intelligence Can Predict GFR Decline During the Course of ADPKD.人工智能可预测常染色体显性多囊肾病病程中的肾小球滤过率下降。
Am J Kidney Dis. 2018 Jun;71(6):911-912. doi: 10.1053/j.ajkd.2018.01.051. Epub 2018 Mar 30.
4
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.常染色体显性多囊肾病中的肌酐管状分泌：对肾功能评估方程的横断面和纵向表现的影响。
Am J Kidney Dis. 2013 Sep;62(3):531-40. doi: 10.1053/j.ajkd.2013.03.030. Epub 2013 May 25.
5
[AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: HOW AND WHY SHOULD WE IDENTIFY THE PATIENTS "RAPIDLY PROGRESSING" TO END-STAGE RENAL DISEASE?].[常染色体显性多囊肾病：我们应如何以及为何要识别那些“快速进展”至终末期肾病的患者？]
Rev Med Liege. 2016 Apr;71(4):184-92.
6
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾血流的磁共振测量与疾病进展
Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. doi: 10.2215/CJN.00910306. Epub 2006 Nov 2.
7
Copeptin levels and kidney function in ADPKD: case-control study.常染色体显性多囊肾病中的 copeptin 水平与肾功能：病例对照研究
Clin Nephrol. 2016 Sep;86(9):147-53. doi: 10.5414/CN108894.
8
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.托伐普坦对不同肾功能水平常染色体显性多囊肾病个体的短期疗效。
Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15.
9
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.尿液核磁共振谱指纹分析检测常染色体显性多囊肾病。
Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.
10
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.一种预测常染色体显性遗传性多囊肾病（ADPKD）患者疾病进展的模型：ADPKD 预后模型。
BMC Nephrol. 2018 Feb 13;19(1):37. doi: 10.1186/s12882-017-0804-2.

引用本文的文献

1
Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.常染色体显性多囊肾病随访与治疗中未满足的需求及挑战：儿科视角
Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17.